Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNMA1 | Q12791 | 2/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.46 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.46 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12204565 | 0.90 | SMN1; SMN2 (0.62) | KCNMA1SMN1; SMN2RAB9APOLBMAPK1 | |
| SCHEMBL15632082 | 0.85 | SMN1; SMN2 (0.57) | KCNMA1SMN1; SMN2RAB9APOLBMAPK1 | |
| SCHEMBL165333 | 0.84 | SMN1; SMN2 (0.71) | KCNMA1SMN1; SMN2RAB9APOLBMAPK1 | |
| SCHEMBL13338045 | 0.84 | KCNMA1 (0.50) | KCNMA1SMN1; SMN2RPS6KA3RAB9APOLB | |
| SCHEMBL4799345 | 0.81 | NPC1 (0.65) | KCNMA1SMN1; SMN2RAB9APOLBMAPK1 | |
| SCHEMBL3977744 | 0.81 | TDP1 (0.56) | KCNMA1SMN1; SMN2RAB9APOLBMAPK1 | |
| SCHEMBL172700 | 0.81 | ALDH1A1 (0.56) | KCNMA1SMN1; SMN2RAB9APOLBMAPK1 | |
| SCHEMBL10069688 | 0.81 | SMN1; SMN2 (0.54) | KCNMA1SMN1; SMN2RAB9APOLBMAPK1 | |
| SCHEMBL16614107 | 0.81 | SMN1; SMN2 (0.58) | KCNMA1SMN1; SMN2RAB9APOLBMAPK1 | |
| SCHEMBL18393241 | 0.81 | SMN1; SMN2 (0.54) | KCNMA1SMN1; SMN2RAB9APOLBMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 368 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117925038-A | Strippable rust inhibitor for surface treatment of infrared thermal wave nondestructive test object and use method thereof | 杭州派肯科技有限公司 | 2024-04-26 | — | — | CN | claimed |
| US-11820844-B2 | Charge-modified particles and methods of making the same | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-11-21 | — | — | US | claimed |
| EP-3319947-B1 | SUBSTITUTED BENZOTRIAZOLE PHENOLS | 3M INNOVATIVE PROPERTIES CO (US) | 2022-05-04 | — | — | EP | claimed |
| CN-113927986-A | Transparent photovoltaic back plate with multilayer structure | 上海海优威应用材料技术有限公司 | 2022-01-14 | — | — | CN | claimed |
| CN-110747656-B | Hydrolysis-resistant high-solid polyurethane synthetic leather and preparation method thereof | 安徽安利材料科技股份有限公司 | 2021-11-19 | — | — | CN | claimed |
| CN-108026054-B | Substituted benzotriazolols | 3M创新有限公司 | 2021-10-15 | — | — | CN | claimed |
| CN-111886316-B | Charge-modified particles and methods of making the same | 3M创新有限公司 | 2021-07-09 | — | — | CN | claimed |
| EP-3768794-B1 | CHARGE-MODIFIED PARTICLES AND METHODS OF MAKING THE SAME | 3M INNOVATIVE PROPERTIES CO (US) | 2021-04-28 | — | — | EP | claimed |
| US-10919867-B2 | Substituted benzotriazole phenols | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2021-02-16 | — | — | US | claimed |
| EP-3768794-A2 | CHARGE-MODIFIED PARTICLES AND METHODS OF MAKING THE SAME | 3M Innovative Properties Company (US) | 2021-01-27 | — | — | EP | claimed |
| US-6890880-B2 | Heat-sensitive recording material | FUJI PHOTO FILM CO., LTD. (JP) | 2005-05-10 | — | — | US | claimed |
| US-20030087758-A1 | Heat-sensitive recording material | FUJI PHOTO FIL CO., LTD. | 2003-05-08 | — | — | US | claimed |
| EP-1291196-A2 | Heat-sensitive recording material | FUJI PHOTO FILM CO., LTD. (JP) | 2003-03-12 | — | — | EP | claimed |
| EP-0786675-B1 | Spectacle lens | TEIJIN CHEMICALS LTD (JP) | 2002-11-06 | — | — | EP | claimed |
| EP-0855393-B1 | BISBENZOTRIAZOLYLPHENOLS | OTSUKA KAGAKU KK (JP) | 2002-08-14 | — | — | EP | claimed |
| US-5952096-A | CONSISTS OF POLYCARBONATE RESIN, TWO ULTRAVIOLET ABSORBERS OF SPECIFIC ABSORPTION WAVELENGTHS; EXCELLENT IMPACT STRENGTH, TRANSPARENCY AND HIGH ABSORPTION POWER FOR ULTRAVIOLET LIGHT HAVING A SPECIFIC WAVELENGTH | TEIJIN CHEMICALS, LTD. (JP) | 1999-09-14 | — | — | US | claimed |
| EP-0786675-A2 | Spectacle lens | Teijin Chemicals, Ltd. (JP) | 1997-07-30 | — | — | EP | claimed |
| EP-0180993-B1 | PROCESS FOR PREPARING 2,2'-METHYLENE-BIS-(4-HYDROCARBYL-6-BENZO-TRIAZOLYLPHENOLS) | ADEKA ARGUS CHEMICAL CO., Ltd. (JP) | 1991-02-27 | — | — | EP | claimed |
| US-4937348-A | Process for preparing 2,2'-methylene-bis-(4-hydrocarbyl-6-benzotriazolylphenols) | ADEKA ARGUS CHEMICAL CO., LTD. (JP) | 1990-06-26 | — | — | US | claimed |
| EP-0180993-A2 | Process for preparing 2,2'-methylene-bis-(4-hydrocarbyl-6-benzo-triazolylphenols) | ADEKA ARGUS CHEMICAL CO., Ltd. (JP) | 1986-05-14 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10919867-B2 | Substituted benzotriazole phenols | TYR, COMT, TH | KCNMA1 3351/4885SMN1; SMN2 4085/4885RPS6KA3 4739/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.